2010 Delegates
In 2010 the following delegates attended the conference:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
| A | |
|---|---|
| A. Menarini .I.F.R. | President of Menarini Biotech |
| Abingworth LLP | Partner |
| Abingworth LLP | Partner |
| Abingworth LLP | Principal |
| Abingworth | President US Division/Director |
| Ablynx NV | Chief Executive Officer and Chairman of the Board |
| Actelion Pharmaceuticals | President, Global Corporate and Business Development |
| ActoGeniX NV | Chief Executive Officer and Chief Medical Officer |
| Addex Pharmaceuticals SA | Chief Executive Officer |
| Aerie Pharmaceuticals Inc | President and Chief Executive Officer |
| Affimed Therapeutics AG | Chief Executive Officer |
| Alder Biopharmaceuticals | President and Chief Executive Officer |
| Angiochem | President and Chief Executive Officer |
| Ansaris | President and Chief Executive Officer |
| Antisoma Research Limited | Chief Executive Officer |
| Astex Therapeutics | Chief Executive Officer |
| Astex Therapeutics | Director |
| Avanir Pharmaceuticals Inc | President and Chief Executive Officer |
| Avila Therapeutics Inc | Vice President Corporate Development and Operations |
| B | |
| Bayer AG | Global Head of Mergers & Acquisitions |
| Bayer AG | Vice President of Mergers & Acquisitions |
| Bayer Shering Pharma AG | Head of GBD&L, Special Projects |
| Biogen Idec | Executive Vice President Corporate and Business Development |
| BioMarin Pharmaceutical | Chief Executive Officer |
| Biovail Corporation | Vice President of Corporate Development |
| Bristol-Myers Squibb Company | Vice President, Strategic Transactions Group |
| C | |
| Cambridge Theranostics Ltd | Chief Executive Officer |
| Catalyst Biosciences Inc | Chief Executive Officer |
| Celgene Corporation | Senior Vice President Business Development |
| Cerenis Therapeutics SA | Senior Vice President Business Development |
| Chroma Therapeutics Ltd | Chief Executive Officer |
| Clarus Ventures | Principal |
| Clovis Oncology Inc | President and Chief Executive Officer |
| CoMentis Inc | Chief Executive Officer |
| Covington & Burling LLP | Partner and co-chair of the Food and Drug practice group |
| Covington & Burling LLP | Partner |
| Covington & Burling LLP | Partner |
| Covington & Burling LLP | Partner |
| Creabilis | Chairman |
| D | |
| Delta G Entrepreneurs and Analysts | President and Chief Operating Officer |
| Deltagen Inc | President and Chief Operating Officer |
| Dendreon Corporation | Executive Vice President and Chief Operating Officer |
| Dendreon Corporation | President and Chief Executive Officer |
| Deutsche Bank | Vice Chairman |
| Deutsche Bank | Managing Director, Healthcare Investment Banking Group |
| Deutsche Bank | Managing Director and Head of European Healthcare M&A |
| Deutsche Bank | Managing Director Healthcare Investment Banking Group |
| Deutsche Bank | Director |
| Deutsche Bank Securities Inc | Co-Head Global Health Care Investment Banking |
| Deutsche Bank Securities Inc | Managing Director |
| E | |
| Edison Pharmaceuticals Inc | Founder, Chief Executive Officer and Chairman |
| EGeen International Corporation | Chief Executive Officer |
| EGeen International Corporation | Member of the Board |
| Eli Lilly and Company | Senior VIce President of Corporate Strategy and Business Development |
| Endo Pharmaceuticals Inc | Senior Vice President, Corporate Development |
| EnVivo Pharmaceuticals Inc | President and Chief Executive Officer |
| EnVivo Pharmaceuticals Inc | Chairman |
| EUSA Pharma | President and Chief Executive Officer |
| F | |
| F. Hoffman-La Roche Ltd | Global Head External Research and Technologies |
| Facet Biotech | President and Chief Executive Officer |
| Ferring | Senior Vice President, Global Operational Management |
| FibroGen Inc | Chairman, Founder, Chief Executive Officer |
| FOVEA Pharmaceuticals | Co Founder, Chief Executive Officer and Chairman of the Board |
| G | |
| Galenica AG | Chairman and Chief Executive Officer |
| Gimv N.V. | Executive Vice President Life Sciences |
| Gimv N.V. | Partner Venture Capital |
| GlaxoSmithKline | Vice President, Business Development & Strategy, APJEM R&D |
| GlaxoSmithKline | Chief Strategy Officer |
| GlobeImmune Inc | President and Chief Executive Officer |
| H | |
| I | |
| Idenix Pharmaceuticals | Chief Financial Officer |
| Intra-Cellular Therapies Inc | Chairman and Chief Executive Officer |
| Investment New Zealand | Investment Manager |
| J | |
| Johnson & Johnson | Executive Vice President, Business Development, Pharmaceuticals Group |
| K | |
| L | |
| Lexicon Pharmaceuticals Inc | President and Chief Executive Officer |
| Lexicon Pharmaceuticals Inc | Chief Scientific Officer |
| Light Sciences Oncology Inc | President and Chief Executive Officer – Light Sciences Oncology |
| Lupin Limited | Managing Director |
| M | |
| MagForce Nanotechnologies AG | Chief Executive Officer |
| Martek Biosciences Corporation | Chief Operating Officer |
| Merck Inc | Senior Vice President Worldwide Licensing and Knowledge Management |
| Merck & Co Inc | Senior Director and Head, Licensing and External Research, Europe |
| Movetis n.v. | Chief Executive Officer |
| N | |
| Novartis Pharma AG | Head of Global Business Development & Licensing |
| NOXXON Pharma AG | Chief Executive Officer |
| O | |
| Oxagen Limited | Chief Executive Officer |
| Oxford BioMedica plc | Chief Executive Officer |
| P | |
| P-A-K Limited | Chief Executive Officer |
| Paratek Pharmaceuticals Inc | President and Chief Executive Officer |
| Pfizer | Vice President, Worldwide Business Development |
| PricewaterhouseCoopers LLP | Partner National Life Sciences Industry Group |
| PricewaterhouseCoopers LLP | Partner, US Pharmaceutical and Life Sciences Advisory Services Leader |
| PricewaterhouseCoopers LLP | Partner, Global Pharmaceutical and Life Sciences Advisory Services Leader |
| PricewaterhouseCoopers | Partner, Global Pharma and Life Sciences Tax Leader |
| PricewaterhouseCoopers | Pharma Life Sciences Leader India |
| PricewaterhouseCoopers | Partner, Pharmaceuticals and Life Sciences, Strategy |
| Probiodrug AG | Chief Financial Officer |
| Prosensa Therapeutics BV | Chief Executive Officer |
| Q | |
| R | |
| Resverlogix Corp | Senior VIce President, Business and Corporate Devlopment |
| Revotar | Chief Executive Officer |
| Rib-X Pharmaceuticals Inc | President and Chief Executive Officer |
| S | |
| sanofi-aventis | Vice President and Chief Patent Counsel (retired) |
| ScinoPharm Taiwan Ltd | Co Founder, Executive Vice President and Chief Scientific Officer |
| Scynexis | President and Chief Executive Officer |
| Sepracor Inc | Senior Vice President, Corporate Development |
| Shire plc | Chief Executive |
| Shire Pharmaceutical Development plc | Business Development Director |
| Sigmoid Pharma | Chief Executive Officer |
| Sofinnova Partners | Partner |
| Sofinnova Partners | Managing Partner |
| Solace Pharmaceuticals (UK) Ltd | Chief Executive Officer |
| Supernus Pharmaceuticals Inc | President and Chief Executive Officer |
| Syndax Pharmaceuticals Inc | President and Chief Executive Officer |
| Syntaxin Ltd | Chief Executive Officer |
| T | |
| Targacept Inc | Senior Vice President, Business and Commercial Development, Chief Business Officer |
| Thrombogenics | Chief Executive Officer |
| Trevena Inc | Chief Executive Officer |
| Trophos | Chief Executive Officer |
| TVM Capital GmbH | General Partner |
| TVM Capital GmbH | General Partner |
| U | |
| V | |
| Vitae Pharmaceuticals | President and Chief Executive Officer |
| Z | |
| Zealand Pharma A/S | Director, Business Development |
